High frequency of aberrant p16(INK4A) expression in human breast cancer.
- 1 July 1996
- journal article
- Vol. 149 (1) , 15-20
Abstract
The product of the CDKN2/MTS1 gene, p16(INK4A) (16), inhibits phosphorylation of the retinoblastoma protein, pRB, and thus acts as a negative cell cycle regulator. It is inactivated in a wide range of human malignancies, including breast cancer. Using an immunohistochemical approach, we studied the expression of both p16 and pRB in 104 archival breast tumors, including 63 ductal, 33 lobular, and 8 mixed carcinomas. All specimens except one were evaluable for pRB expression, but only 87 were interpretable for p16 expression, reflecting the lower abundance and greater lability of this protein. Only six tumors showed abnormal RB expression. However, 43 carcinomas (49%) were completely (35) or focally (8) negative for p16. Abnormal p16 expression did not significantly correlate with several histopathological parameters. These findings provide evidence that aberrant p16(INK4A) expression is one of the most common abnormalities in human breast cancer.This publication has 23 references indexed in Scilit:
- Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.1995
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.1995
- Association between rb‐1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survivalInternational Journal of Cancer, 1995
- Analysis of MTS1/CDK4 in female breast carcinomasCancer Letters, 1995
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodiesInternational Journal of Cancer, 1994
- Retinoblastoma protein monoclonal antibodies with novel characteristicsJournal of Immunological Methods, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Structural Rearrangement of the Retinoblastoma Gene in Human Breast CarcinomaScience, 1988